ACT-774312
- Generic Name
- ACT-774312
A Study to Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal Polyposis
- First Posted Date
- 2018-09-28
- Last Posted Date
- 2022-04-11
- Lead Sponsor
- Idorsia Pharmaceuticals Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT03688555
- Locations
- 🇧🇪
University Hospital Ghent, Gent, Belgium
🇩🇪Charité Research Organisation GmbH, Berlin, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath